Amphastar pharmaceuticals reports financial results for the three months ended june 30, 2021

Reports net revenues of $101.7 million for the three months ended june 30, 2021 rancho cucamonga, ca / accesswire / august 9, 2021 / amphastar pharmaceuticals, inc. (nasdaq:amph) ("amphastar" or the "company") today reported results for the three months ended june 30, 2021. second quarter highlights net revenues of $101.7 million for the second quarter gaap net income of $7.8 million, or $0.16 per share, for the second quarter adjusted non-gaap net income of $10.6 million, or $0.21 per share, for the second quarter dr. jack zhang, amphastar's president and chief executive officer, commented: "continued strong sales of glucagon, primatene mist® and our epinephrine products led to another strong quarter of growth.
AMPH Ratings Summary
AMPH Quant Ranking